Literature DB >> 10048375

Quantitative analysis of diabetic macular edema after scatter laser photocoagulation with the scanning retinal thickness analyzer.

A Tsujikawa1, J Kiryu, J Dong, T Yasukawa, I Suzuma, H Takagi, Y Ogura.   

Abstract

PURPOSE: To define the effect of scatter laser photocoagulation on foveal retinal thickness.
METHODS: A commercial scanning retinal thickness analyzer was used to measure retinal thickness. The foveal retinal thickness was measured at the central area of the fundus (0.4 x 0.4 mm). The method was applied to 20 consecutive patients (mean age, 52.4 +/-16.9 years) with diabetic retinopathy. Measurements were performed before and 6 weeks after scatter photocoagulation. Patients were examined by fluorescein angiography and slit-lamp biomicroscopy to detect macular edema.
RESULTS: Mean foveal thickness before scatter photocoagulation was 187+/-45 microm, increasing to 221+/-46 microm after the treatment (P = 0.0001). The foveal thickness increased in 12 eyes (60%). Laser treatment increased macular permeability in two eyes (10%). Biomicroscopic examination revealed central macular thickening in one eye (5%). Visual acuity was reduced in four eyes (20%).
CONCLUSIONS: Our results suggest that subclinical macular edema occurs after scatter laser photocoagulation. The retinal thickness analyzer is a sensitive tool for early detection of macular edema after laser treatment, because increases in retinal thickness as small as 34 microm cannot be assessed by slit-lamp biomicroscopy.

Entities:  

Mesh:

Year:  1999        PMID: 10048375     DOI: 10.1097/00006982-199901000-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Eccentricity and measurement variability and repeatability with the retinal thickness analyser.

Authors:  E D Gilmore; C Hudson
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.

Authors:  Monica Lövestam-Adrian; Sten Andréasson; Vesna Ponjavic
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

3.  Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.

Authors:  Irina G Obrosova; Yury Maksimchyk; Pal Pacher; Elisabet Agardh; Maj-Lis Smith; Azza B El-Remessy; Carl-David Agardh
Journal:  Int J Mol Med       Date:  2010-07       Impact factor: 4.101

4.  Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period.

Authors:  R Filek; P Hooper; T Sheidow; J Gonder; D K Varma; L Heckler; W Hodge; S Chakrabarti; C M L Hutnik
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

5.  Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier.

Authors:  B Sander; M Larsen; C Engler; B Moldow; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  Diagnostic accuracy of the Retinal Thickness Analyser: differentiation between normal eyes and eyes with glaucoma or macular pathologies.

Authors:  Philip Maier; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

7.  Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.

Authors:  J Fernando Arevalo; Juan G Sanchez; Andres F Lasave; Lihteh Wu; Mauricio Maia; Sergio Bonafonte; Miguel Brito; Arturo A Alezzandrini; Natalia Restrepo; Maria H Berrocal; Mario Saravia; Michel Eid Farah; Jans Fromow-Guerra; Virgilio Morales-Canton
Journal:  J Ophthalmol       Date:  2011-03-30       Impact factor: 1.909

Review 8.  Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy.

Authors:  J Fernando Arevalo
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.